As Globus Med INC (GMED) Shares Rose, Pura Vida Investments LLC Has Upped by $3.39 Billion Its Position

April 25, 2018 - By Kurt Siggers

Globus Medical, Inc. (NYSE:GMED) LogoInvestors sentiment decreased to 0.99 in 2017 Q4. Its down 0.39, from 1.38 in 2017Q3. It dropped, as 26 investors sold GMED shares while 83 reduced holdings. 40 funds opened positions while 68 raised stakes. 59.89 million shares or 7.54% less from 64.77 million shares in 2017Q3 were reported. Vanguard Grp has 0.01% invested in Globus Medical, Inc. (NYSE:GMED). Louisiana State Employees Retirement invested in 18,300 shares. Adage Prtnrs Group Limited Co has 160,000 shares. The New York-based Citigroup Inc has invested 0% in Globus Medical, Inc. (NYSE:GMED). Denver Invest Advsrs Limited owns 25,852 shares. Orrstown Services has 0% invested in Globus Medical, Inc. (NYSE:GMED). Liberty Mutual Asset Management holds 0.02% in Globus Medical, Inc. (NYSE:GMED) or 18,329 shares. Ahl Prtnrs Llp owns 0.13% invested in Globus Medical, Inc. (NYSE:GMED) for 203,408 shares. M&T State Bank holds 10,399 shares. Redmile Grp Limited accumulated 208,600 shares. Fiera Cap Corporation accumulated 157,083 shares. Thompson Davis & stated it has 0.01% in Globus Medical, Inc. (NYSE:GMED). Anchor Cap Advsr Ltd Co stated it has 533,162 shares. Alps, a Colorado-based fund reported 15,299 shares. Moreover, Qs has 0% invested in Globus Medical, Inc. (NYSE:GMED) for 1,615 shares.

Pura Vida Investments Llc increased its stake in Globus Med Inc (GMED) by 82.5% based on its latest 2017Q4 regulatory filing with the SEC. Pura Vida Investments Llc bought 82,500 shares as the company’s stock rose 22.30% while stock markets declined. The institutional investor held 182,500 shares of the health care company at the end of 2017Q4, valued at $7.50 billion, up from 100,000 at the end of the previous reported quarter. Pura Vida Investments Llc who had been investing in Globus Med Inc for a number of months, seems to be bullish on the $4.99B market cap company. The stock decreased 1.22% or $0.64 during the last trading session, reaching $51.66. About 1.01 million shares traded or 62.13% up from the average. Globus Medical, Inc. (NYSE:GMED) has risen 65.36% since April 25, 2017 and is uptrending. It has outperformed by 53.81% the S&P500.

Pura Vida Investments Llc, which manages about $223.00M and $134.97B US Long portfolio, decreased its stake in Penumbra Inc by 44,579 shares to 15,000 shares, valued at $1.41B in 2017Q4, according to the filing. It also reduced its holding in Invacare Corp (NYSE:IVC) by 222,726 shares in the quarter, leaving it with 277,274 shares, and cut its stake in Deciphera Pharmaceuticals In.

Globus Medical, Inc. (NYSE:GMED) Ratings Coverage

Among 9 analysts covering Globus Medical (NYSE:GMED), 6 have Buy rating, 1 Sell and 2 Hold. Therefore 67% are positive. Globus Medical had 14 analyst reports since November 9, 2017 according to SRatingsIntel. Canaccord Genuity maintained it with “Buy” rating and $47.0 target in Thursday, January 4 report. Leerink Swann maintained Globus Medical, Inc. (NYSE:GMED) on Wednesday, March 28 with “Buy” rating. The firm earned “Overweight” rating on Thursday, February 22 by Morgan Stanley. On Monday, April 16 the stock rating was downgraded by BTIG Research to “Neutral”. Canaccord Genuity maintained Globus Medical, Inc. (NYSE:GMED) on Thursday, February 22 with “Buy” rating. The stock of Globus Medical, Inc. (NYSE:GMED) has “Buy” rating given on Tuesday, January 9 by Piper Jaffray. As per Thursday, November 9, the company rating was maintained by Barclays Capital. As per Friday, November 10, the company rating was upgraded by Bank of America. The stock of Globus Medical, Inc. (NYSE:GMED) has “Buy” rating given on Wednesday, November 8 by Canaccord Genuity. The firm earned “Buy” rating on Wednesday, April 4 by Needham.

Globus Medical, Inc. (NYSE:GMED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.